Skip to main content

Table 4 Association between hemoglobin or anemia and fall, by sex and age, OR (CI). The Tromsø Study 2001-02

From: The association between anemia and falls in community-living women and men aged 65 years and older from the fifth Tromsø Study 2001-02: a replication study

 

Unadjusted model

Model 1b

Model 2c

Model 3d

Hemoglobin level (continuous, per SD decrease)

 Total sample

1.03 (0.94-1.12)

1.01 (0.92-1.11)

1.03 (0.93-1.14)

0.94 (0.81-1.09)

 Age 65-74

1.04 (0.93-1.15)

1.04 (0.92-1.17)

1.09 (0.95-1.25)

1.06 (0.85-1.32)

 Age ≥ 75

0.98 (0.85-1.14)

0.97 (0.83-1.13)

0.94 (0.80-1.11)

0.87 (0.71-1.05)

 Women

1.06 (0.93-1.22)

1.06 (0.93-1.22)

1.02 (0.88-1.19)

0.85 (0.62-1.05)

 Age 65-74

1.13 (0.94-1.35)

 

1.09 (0.89-1.34)

0.79 (0.55-1.11)

 Age ≥ 75

0.97 (0.79-1.20)

 

0.94 (0.75-1.18)

0.90 (0.69-1.17)

 Men

0.98 (0.86-1.11)

0.97 (0.85-1.10)

1.03 (0.89-1.20)

1.06 (0.87-1.30)

 Age 65-74

0.97 (0.82-1.14)

 

1.09 (0.90-1.31)

1.40 (1.03-1.91)

 Age ≥ 75

0.97 (0.78-1.20)

 

0.94 (0.74-1.21)

0.84 (0.63-1.11)

Anemiaa

 Total sample

1.03 (0.75-1.41)

1.02 (0.74-1.40)

1.00 (0.70-1.44)

0.83 (0.50-1.37)

 Age 65-74

1.05 (0.67-1.63)

1.05 (0.68-1.63)

1.06 (0.64-1.77)

1.15 (0.52-2.55)

 Age ≥ 75

0.95 (0.60-1.50)

0.96 (0.61-1.52)

0.92 (0.55-1.56)

0.69 (0.36-1.32)

 Women

1.15 (0.73-1.82)

1.15 (0.73-1.82)

1.05 (0.62-1.77)

0.55 (0.23-1.29)

 Age 65-74

1.10 (0.59-2.05)

 

0.96 (0.46-2.00)

0.44 (0.09-2.03)

 Age ≥ 75

1.16 (0.59-2.29)

 

1.11 (0.52-2.36)

0.64 (0.22-1.84)

 Men

0.94 (0.61-1.46)

0.90 (0.58-1.40)

0.95 (0.57-1.58)

1.08 (0.57-2.03)

 Age 65-74

1.00 (0.53-1.88)

 

1.17 (0.57-2.38)

2.17 (0.76-6.22)

 Age ≥ 75

0.83 (0.45-1.54)

 

0.78 (0.38-1.62)

0.72 (0.32-1.65)

  1. OR Odds Ratios, CI Confidence Intervals
  2. aWHO criteria (<12 g/dl in women, <13 g/dl in men)
  3. bModel 1: Adjusted for age (years, only for the total sample and in sex-stratified analyses) and sex (only in the total sample and in the age-stratified analyses)
  4. cModel 2: In addition to Model 1 adjusted for number of drugs (self-reported)
  5. dModel 3: In addition to Model 2 adjusted for disability (self-reported)